Clinical trial
A Randomized and Controlled Study of Efficacy and Safety of Bovine Pericardial Patch and TiLOOP® Bra Mesh in Patients With Immediate Implant Breast Reconstruction.
NCT04245930 is registered in ClinicalTrials.gov with Tianjin Medical University Cancer Institute and Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized and Controlled Study of Efficacy and Safety of Bovine Pericardial Patch and TiLOOP® Bra Mesh in Patients With Immediate Implant Breast Reconstruction.
- Lead sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2020
- Completion date
- December 31, 2022
- Enrollment
- 176 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bovine pericardial patch, implant breast reconstruction, tiloop® bra mesh